Target intelligence / Profile preview

DNA damage via localized beta radiation from iodine-131

Molecular classification
Other (radiation-induced DNA damage mechanism/process)
01

Overview

Iodine-131 emits beta particles that deposit energy over millimeter-scale paths; when localized near or within cells (e.g., thyroid tissue taking up radioiodide), these beta emissions produce predominantly indirect DNA damage through ROS, along with some direct ionization, resulting in SSBs, DSBs, and base damage. Cells mount a DNA damage response involving ATM/ATR signaling, γ-H2AX and 53BP1 foci formation, and engage BER and NHEJ (and HR in S/G2); outcomes include cell-cycle arrest, apoptosis, or mutagenesis. Experimental studies show I-131 beta particles induce measurable strand breaks in cultured cells, and can trigger apoptosis and G2/M arrest; in patients and lymphocyte models, genotoxicity can be monitored by micronuclei. While therapeutically exploited in thyroid disease, off-target genomic damage underlies radiation toxicity and secondary cancer risks.

Other names
Beta-radiation–induced DNA damageDNA lesions from beta particlesGenomic damage by beta radiationIodine-131–induced DNA damage
02

Mechanism of action

Indirect DNA damage via reactive oxygen species from water radiolysis leading to single-strand breaks, double-strand breaks, and base/sugar modifications Direct ionization of DNA by beta particles causing SSBs and reversible DSBs Downstream activation of DNA damage response pathways (BER for SSB/base damage; NHEJ for DSBs; HR in S/G2)

03

Biological functions

Genome integrity/DNA repair response activation (BER, NHEJ; also HR for replication-associated breaks)Cell cycle checkpoint activation (G1/S/G2 arrest via ATM/ATR/CHK1/CHK2/p53)Apoptosis and cell death signaling (intrinsic and extrinsic pathways; caspase activation)
04

Disease associations

Cancer (therapeutic cytotoxic mechanism in radioiodine therapy; also mutagenic risk)Radiation toxicity (normal-tissue injury)Genomic instability (mutations, micronuclei)
05

Safety considerations

Normal tissue toxicity from off-target beta irradiationGenomic instability and secondary malignancy risk (e.g., increased leukemia incidence reported after I-131 therapy)Dose, uptake heterogeneity, oxygenation status influencing extent and complexity of DNA damage and repairability
06

Interacting drugs

Iodine-131 radiopharmaceuticals (e.g., sodium iodide I-131 used for thyroid diseases)

1 more in the full profile.

07

Biomarkers

γ-H2AX nuclear foci (Ser139-phosphorylated H2AX) indicating DSBs53BP1 foci at DSB sitesPARP activity/cleavage reflecting SSB repair and apoptosis signalingMicronucleus frequency in peripheral lymphocytes as a genotoxicity marker after I-131 exposure

Beyond the preview

Go deeper on DNA damage via localized beta radiation from iodine-131.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA damage via localized beta radiation from iodine-131.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call